Dupilumab for the Treatment of Chronic Actinic Dermatitis: A Systematic Review
International Journal of Dermatology · 2026-12 · 65 (12) · 2620-2622
DOI: 10.1111/ijd.70542 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 13.06.2026. Verfasst von Anagha Srivatsa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wayne State University School of Medicine, Detroit, Michigan, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Wayne State University School of Medicine, Detroit, Michigan, USA.
- Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan, USA.
- Department of Dermatology, Wayne State University, Detroit, Michigan, USA.
ORCID-Profile: Anagha Srivatsa, Marissa Yaldo, Hunter Cohn, Wasey Rehman, Rafey Rehman, Meena Moossavi, Geoffrey Potts, Darius Mehregan
Zitieren
APA
Srivatsa, A., Yaldo, M., Cohn, H., Rehman, W., Rehman, R., Moossavi, M., Potts, G., & Mehregan, D. (2026). Dupilumab for the Treatment of Chronic Actinic Dermatitis: A Systematic Review. International Journal of Dermatology, 65(12), 2620-2622. https://doi.org/10.1111/ijd.70542
Vancouver
Srivatsa A, Yaldo M, Cohn H, Rehman W, Rehman R, Moossavi M, et al. Dupilumab for the Treatment of Chronic Actinic Dermatitis: A Systematic Review. International Journal of Dermatology. 2026;65(12):2620-2622. doi:10.1111/ijd.70542
BibTeX
@article{Srivatsa2026,
author = {Srivatsa, Anagha and Yaldo, Marissa and Cohn, Hunter and Rehman, Wasey and Rehman, Rafey and Moossavi, Meena and Potts, Geoffrey and Mehregan, Darius},
title = {Dupilumab for the Treatment of Chronic Actinic Dermatitis: A Systematic Review},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {12},
pages = {2620--2622},
doi = {10.1111/ijd.70542}
}
EUVIMED